131 related articles for article (PubMed ID: 14510644)
1. Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models.
Blomqvist M; Osterbye T; Månsson JE; Horn T; Buschard K; Fredman P
APMIS; 2003 Sep; 111(9):867-77. PubMed ID: 14510644
[TBL] [Abstract][Full Text] [Related]
2. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking.
Fredman P; Mânsson JE; Rynmark BM; Josefsen K; Ekblond A; Halldner L; Osterbye T; Horn T; Buschard K
Glycobiology; 2000 Jan; 10(1):39-50. PubMed ID: 10570222
[TBL] [Abstract][Full Text] [Related]
3. In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats.
Blomqvist M; Carrier M; Andrews T; Pettersson K; Månsson JE; Rynmark BM; Fredman P; Buschard K
Diabetes Metab Res Rev; 2005; 21(2):158-66. PubMed ID: 15580649
[TBL] [Abstract][Full Text] [Related]
4. Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans.
Blomqvist M; Osterbye T; Månsson JE; Buschard K; Fredman P
Lipids Health Dis; 2006 Oct; 5():26. PubMed ID: 17044925
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line.
Blomqvist M; Osterbye T; Månsson JE; Horn T; Buschard K; Fredman P
Glycoconj J; 2002 Jul; 19(6):403-13. PubMed ID: 14707487
[TBL] [Abstract][Full Text] [Related]
6. C16:0 sulfatide inhibits insulin secretion in rat beta-cells by reducing the sensitivity of KATP channels to ATP inhibition.
Buschard K; Blomqvist M; Månsson JE; Fredman P; Juhl K; Gromada J
Diabetes; 2006 Oct; 55(10):2826-34. PubMed ID: 17003349
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression of the type I diabetes related antigen sulfatide and sulfated lactosylceramide in mammalian pancreas.
Blomqvist M; Kaas A; Månsson JE; Formby B; Rynmark BM; Buschard K; Fredman P
J Cell Biochem; 2003 May; 89(2):301-10. PubMed ID: 12704793
[TBL] [Abstract][Full Text] [Related]
8. Involvement of sulfatide in beta cells and type 1 and type 2 diabetes.
Buschard K; Blomqvist M; Osterbye T; Fredman P
Diabetologia; 2005 Oct; 48(10):1957-62. PubMed ID: 16143863
[TBL] [Abstract][Full Text] [Related]
9. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
10. Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice.
Rhost S; Lofbom L; Mansson J-; Lehuen A; Blomqvist M; Cardell SL
Scand J Immunol; 2014 Apr; 79(4):260-6. PubMed ID: 24795987
[TBL] [Abstract][Full Text] [Related]
11. Abnormal islet sphingolipid metabolism in type 1 diabetes.
Holm LJ; Krogvold L; Hasselby JP; Kaur S; Claessens LA; Russell MA; Mathews CE; Hanssen KF; Morgan NG; Koeleman BPC; Roep BO; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
Diabetologia; 2018 Jul; 61(7):1650-1661. PubMed ID: 29671030
[TBL] [Abstract][Full Text] [Related]
12. The C24:0 Sulfatide Isoform as an Important Molecule in Type 1 Diabetes.
Buschard K; Antvorskov JC
Front Biosci (Landmark Ed); 2022 Dec; 27(12):331. PubMed ID: 36624946
[TBL] [Abstract][Full Text] [Related]
13. Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice.
Buschard K; Hanspers K; Fredman P; Reich EP
Autoimmunity; 2001; 34(1):9-17. PubMed ID: 11681495
[TBL] [Abstract][Full Text] [Related]
14. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry.
Hirahara Y; Wakabayashi T; Mori T; Koike T; Yao I; Tsuda M; Honke K; Gotoh H; Ono K; Yamada H
J Neurochem; 2017 Feb; 140(3):435-450. PubMed ID: 27861899
[TBL] [Abstract][Full Text] [Related]
15. Sulfatide with short fatty acid dominates in astrocytes and neurons.
Isaac G; Pernber Z; Gieselmann V; Hansson E; Bergquist J; Månsson JE
FEBS J; 2006 Apr; 273(8):1782-90. PubMed ID: 16623713
[TBL] [Abstract][Full Text] [Related]
16. Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells.
Buschard K; Høy M; Bokvist K; Olsen HL; Madsbad S; Fredman P; Gromada J
Diabetes; 2002 Aug; 51(8):2514-21. PubMed ID: 12145165
[TBL] [Abstract][Full Text] [Related]
17. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
18. PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets.
Portela-Gomes GM; Lukinius A; Ljungberg O; Efendic S; Ahrén B; Abdel-Halim SM
Regul Pept; 2003 May; 113(1-3):31-9. PubMed ID: 12686458
[TBL] [Abstract][Full Text] [Related]
19. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of type 2 diabetes susceptibility genes in the pancreatic islets, adipose tissue and liver of obese mice.
Morrison F; Locke J; Arif M; Murray A; Brown JE; Harries LW
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):413-9. PubMed ID: 23839539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
